Corcept Therapeutics | CORT - Marktkapitalisierung

Aktienkurs
33.24
Täglich Wechseln
-0.27 -0.81%
Monatlich
-2.92%
Jährlich
-42.69%
Q1 Prognose
31.18




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Alaunos Therapeutics USD 5M 2M 2025-09
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Ardelyx USD 1.33B 390M 2025-09
Aurora Cannabis CAD 470.14M 146.16M 2025-09
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 781.35M 426.11M 2025-09
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
J&J USD 500.24B 67.44B 2025-12
Knight Therapeutics CAD 624.22M 38.25M 2026-03
Lexicon Pharmaceuticals USD 416M 2M 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 265.66B 9.48B 2025-09
Novartis USD 246.07B 11.81B 2025-09
Pacira USD 1.06B 94M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12